New York, NY, Feb. 04, 2019 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Sepsis Diagnostics Market by Product (Instruments, Blood Culture Media, and Assay Kits and Reagents), by Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, Microfluidics, and Biomarkers), by Pathogen Type (Bacterial Sepsis [Gram-Positive Bacteria and Gram-Negative Bacteria], Fungal Sepsis, and Others), by Method (Conventional Diagnostics and Automated Diagnostics), and by Test Type (Laboratory Tests and Point-Of-Care Tests): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2025”. According to the report, the global sepsis diagnostics market was valued at approximately USD 441 million in 2018 and is expected to generate around USD 792 million by 2025, at a CAGR of around 8.70% between 2019 and 2025.
Sepsis is a life-threatening condition caused by bacterial infection. This disease injures the tissues and organs. As per physicians, it is a three-staged syndrome disease—sepsis, severe sepsis, and septic shock. Severe sepsis is associated with acute alteration in the mental status and organ dysfunction, whereas septic shock is defined as severe sepsis with signs of rapidly falling blood pressure, organ dysfunction, and abnormalities in cellular metabolism, all of which are considered as medical emergencies.
Browse through 88 Tables & 38 Figures spread over 110 Pages and in-depth TOC on “Global Sepsis Diagnostics Market Size 2018: Industry Type, Share, Trends, Segments, Analysis and Forecast 2025”.
Request Free Sample Report of Global Sepsis Diagnostics Market Report @ https://www.zionmarketresearch.com/sample/sepsis-diagnostics-market
The increasing demand for antibiotic-resistant bacterial strains and growing incidences of hospital-acquired infections are likely to boost the sepsis diagnostics market globally in the future. The rising incidences of HAI’s (hospital-acquired infections) are anticipated to be the major growth driver of the global sepsis diagnostics market in the upcoming years. HAIs trigger sepsis mainly in individuals who have weak immunity or are at an increased risk of being diagnosed with chronic diseases.
The global sepsis diagnostics market is segmented on the basis of product, technology, pathogen type, method, and test type. By product type, the market is segmented into blood culture media, assay kits and reagents, and instruments. Blood culture media is likely to hold the largest share of the sepsis diagnostics market over the forecast timeline, owing to the huge demand for cost-effective and standard methods of testing by clinicians. The technology segment includes immunoassays, microbiology, microfluidics, molecular diagnostics, biomarkers, and flow cytometry. The microbiology segment is likely to dominate the sepsis diagnostics market globally in the future, owing to its ability to determine microorganisms for sepsis diagnosis via culture media test applications quantitatively.
Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/sepsis-diagnostics-market
By pathogen type, the sepsis diagnostics market includes fungal sepsis, bacterial sepsis, and others. The bacterial sepsis segment is further segmented into gram-negative bacteria and gram-positive bacteria. The bacterial sepsis segment held the largest market share in 2017, as most patients are affected by gram-negative bacterial sepsis. Furthermore, the fungal sepsis segment is likely to register the highest CAGR in the future, due to the high prevalence of Candida infection resulting in septic poisoning among the patients. By the method, the sepsis diagnostics market includes automated diagnostics and conventional diagnostics. The conventional diagnostics segment held the largest market share in 2017, owing to its cost-effectiveness and ability to make timely changes for appropriate therapy. By test type, the market is bifurcated into laboratory tests and point-of-care tests. Laboratory tests held the maximum market share in 2017, as a large number of blood culture tests are conducted in laboratories.
By region, North America is anticipated to dominate the sepsis diagnostics market globally and hold a major share over the forecast timeline. This can be attributed to the growing adoption of advanced and new diagnostic techniques, rising demand for better healthcare facilities, increasing incidences of chronic diseases, such as diabetes, cancer, etc. leading to increased hospital admissions, and high per capita healthcare expenditure.
Browse the full “Sepsis Diagnostics Market by Product (Instruments, Blood Culture Media, and Assay Kits and Reagents), by Technology (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, Microfluidics, and Biomarkers), by Pathogen Type (Bacterial Sepsis [Gram-Positive Bacteria and Gram-Negative Bacteria], Fungal Sepsis, and Others), by Method (Conventional Diagnostics and Automated Diagnostics), and by Test Type (Laboratory Tests and Point-Of-Care Tests): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2025” Report at https://www.zionmarketresearch.com/report/sepsis-diagnostics-market
Europe is the second largest market for sepsis diagnostics globally and held nearly 31% revenue share of this global market in 2017. With increasing cases of sepsis, the mortality rate of hospitalized patients has increased in the U.S. and Canada. There was an increase of around 6.1% in sepsis cases from 2009 to 2015, i.e., from 200,500 in 2009 to 279, 550 in 2015, reflecting a need for early diagnosis of sepsis. In the UK and Germany, the rate of sepsis diagnosis is high due to the high adoption rates of these devices that are integrated with advanced technology. The growing geriatric population that is more susceptible to chronic infections is anticipated to further drive the sepsis diagnostic market in the European in the years ahead.
The Asia Pacific region is projected to register the highest CAGR over the estimated timeframe. This can be attributed to the geriatric population, rapidly expanding healthcare infrastructure, and an increase in the prevalence of chronic diseases in China, India, and Australia.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/sepsis-diagnostics-market
The Middle East and Africa and LATAM are estimated to be the most potential markets, owing to the growing incidence of chronic diseases and opportunities provided by the government to companies for conducting research and development activities to develop new products for improved patient health.
Some leading players of the global sepsis diagnostics market are Danaher, Immunexpress, Biomerieux, Thermo Fisher Scientific, Becton, Dickinson, and Company, Response Biomedical, Bruker, Luminex, Roche Diagnostics, and T2 Biosystems.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/3787
This report segments the global sepsis diagnostics market into:
Global Sepsis Diagnostics Market: Product Analysis
- Blood Culture Media
- Assay Kits and Reagents
Global Sepsis Diagnostics Market: Technology Analysis
- Molecular Diagnostics
- Flow Cytometry
Global Sepsis Diagnostics Market: Pathogen Type Analysis
- Bacterial Sepsis
- Gram-Positive Bacteria
- Gram-Negative Bacteria
- Fungal Sepsis
Global Sepsis Diagnostics Market: Method Analysis
- Conventional Diagnostics
- Automated Diagnostics
Global Sepsis Diagnostics Market: Test Type Analysis
- Laboratory Tests
- Point-Of-Care Tests
Global Sepsis Diagnostics Market: Regional Analysis
- North America
- The U.S.
- Asia Pacific
- Latin America
- The Middle East and Africa
- Angiographic Catheters Market: https://www.zionmarketresearch.com/report/angiographic-catheters-market
- Autoinjectors Market: https://www.zionmarketresearch.com/report/autoinjectors-market
- Structural Heart Devices Market: https://www.zionmarketresearch.com/report/structural-heart-devices-market
- Medical Equipment Maintenance Market: https://www.zionmarketresearch.com/report/medical-equipment-maintenance-market
- Angiography Equipment Market: https://www.zionmarketresearch.com/report/angiography-equipment-market
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research
Blog: http://usindustrynews.com | http://europeindustrynews.com | http://zmrresearchnews.us | http://zmrmarketjournal.com
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651